Literature DB >> 31066862

Association of Psoriasis With Mental Health Disorders in South Korea.

Chul Hwan Bang1, Jae Woong Yoon2, Jae Heon Chun2, Ju Hee Han1, Young Min Park1, Suk Jun Lee2, Ji Hyun Lee1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31066862      PMCID： PMC6506891          DOI： 10.1001/jamadermatol.2019.0315

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  6 in total

Review 1.  Psoriasis and sleep disorders: A systematic review.

Authors:  Madhulika A Gupta; Fiona C Simpson; Aditya K Gupta
Journal:  Sleep Med Rev       Date:  2015-09-21       Impact factor: 11.609

2.  The role of interleukin (IL)-17 in anxiety and depression of patients with rheumatoid arthritis.

Authors:  Yang Liu; Roger Chun-Man Ho; Anselm Mak
Journal:  Int J Rheum Dis       Date:  2011-09-21       Impact factor: 2.454

3.  Enhanced Th17 phenotype in individuals with generalized anxiety disorder.

Authors:  Morgana M M Vieira; Thais B Ferreira; Paulo A F Pacheco; Priscila O Barros; Carla R M Almeida; Carlos Fernando Araújo-Lima; Renato G Silva-Filho; Joana Hygino; Regis M Andrade; Ulisses C Linhares; Arnaldo F B Andrade; Cleonice A M Bento
Journal:  J Neuroimmunol       Date:  2010-08-14       Impact factor: 3.478

Review 4.  The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis.

Authors:  Emmilia A Dowlatshahi; Marlies Wakkee; Lidia R Arends; Tamar Nijsten
Journal:  J Invest Dermatol       Date:  2013-11-27       Impact factor: 8.551

Review 5.  Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities.

Authors:  James G Krueger; Patrick M Brunner
Journal:  Exp Dermatol       Date:  2017-12-29       Impact factor: 3.960

6.  The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries.

Authors:  Florence J Dalgard; Uwe Gieler; Lucia Tomas-Aragones; Lars Lien; Francoise Poot; Gregor B E Jemec; Laurent Misery; Csanad Szabo; Dennis Linder; Francesca Sampogna; Andrea W M Evers; Jon Anders Halvorsen; Flora Balieva; Jacek Szepietowski; Dmitry Romanov; Servando E Marron; Ilknur K Altunay; Andrew Y Finlay; Sam S Salek; Jörg Kupfer
Journal:  J Invest Dermatol       Date:  2014-12-18       Impact factor: 8.551
  6 in total
  4 in total

1.  Prevalence and Odds of Anxiety Disorders and Anxiety Symptoms in Children and Adults with Psoriasis: Systematic Review and Meta-analysis.

Authors:  Isabelle Jalenques; Fabien Bourlot; Elisa Martinez; Bruno Pereira; Michel D'Incan; Sophie Lauron; Fabien Rondepierre
Journal:  Acta Derm Venereol       Date:  2022-08-26       Impact factor: 3.875

Review 2.  Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review.

Authors:  Jin Bu; Ruilian Ding; Liangjia Zhou; Xiangming Chen; Erxia Shen
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

3.  Risk of End-Stage Renal Disease in Psoriatic Patients: Real-World Data from a Nationwide Population-Based Cohort Study.

Authors:  Eun Lee; Ju Hee Han; Chul Hwan Bang; Seung Ah Yoo; Kyung Do Han; Ha-Na Kim; Young Min Park; Jun Young Lee; Ji Hyun Lee
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379

4.  Increased risk of Alzheimer's disease in patients with psoriasis: a nationwide population-based cohort study.

Authors:  Miri Kim; Hyo Eun Park; Si-Hyung Lee; Kyungdo Han; Ji Hyun Lee
Journal:  Sci Rep       Date:  2020-04-15       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.